Torrent Company Profile
✉ Email this page to a colleague
What is the competitive landscape for TORRENT, and what generic and branded alternatives to TORRENT drugs are available?
TORRENT has one hundred and one approved drugs.
There are seven tentative approvals on TORRENT drugs.
Summary for Torrent
US Patents: | 0 |
Tradenames: | 87 |
Ingredients: | 86 |
NDAs: | 101 |
Patent Litigation for Torrent: | See patent lawsuits for Torrent |
PTAB Cases with Torrent as petitioner: | See PTAB cases with Torrent as petitioner |
Drugs and US Patents for Torrent
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Torrent Pharms | AMLODIPINE BESYLATE | amlodipine besylate | TABLET;ORAL | 078573-001 | Sep 22, 2008 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Torrent Pharms | ISOSORBIDE MONONITRATE | isosorbide mononitrate | TABLET, EXTENDED RELEASE;ORAL | 200495-001 | Jun 3, 2011 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Torrent | SORAFENIB TOSYLATE | sorafenib tosylate | TABLET;ORAL | 217095-001 | Apr 12, 2023 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Torrent | LAMOTRIGINE | lamotrigine | TABLET, EXTENDED RELEASE;ORAL | 203370-003 | Dec 23, 2013 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Torrent Pharms Ltd | OLANZAPINE | olanzapine | TABLET;ORAL | 091434-003 | Apr 23, 2012 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Torrent | FLUOXETINE HYDROCHLORIDE | fluoxetine hydrochloride | TABLET;ORAL | 206937-001 | Oct 21, 2016 | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Torrent Pharms | TOPIRAMATE | topiramate | TABLET;ORAL | 079153-002 | Mar 27, 2009 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.